Entecavir administration to pregnant Japanese woman with chronic hepatitis B and hepatocellular carcinoma: A case report

Women taking entecavir hydrate (ETV) may not need to consider abortion in the event of an unexpected pregnancy. If a woman with renal dysfunction and taking ETV for chronic hepatitis B becomes pregnant, continuous use of ETV may also be tolerated.

Detalles Bibliográficos
Autores principales: Kakiuchi, Toshihiko, Takahashi, Hirokazu, Iwane, Shinji, Koji, Azusa, Matsuo, Muneaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981745/
https://www.ncbi.nlm.nih.gov/pubmed/33768929
http://dx.doi.org/10.1002/ccr3.3896
Descripción
Sumario:Women taking entecavir hydrate (ETV) may not need to consider abortion in the event of an unexpected pregnancy. If a woman with renal dysfunction and taking ETV for chronic hepatitis B becomes pregnant, continuous use of ETV may also be tolerated.

Ejemplares similares